Harvard professor and physician Ashish Jha describes how poor quality medicines create the perfect opportunity for superbugs.
You might also like...
// September 21, 2023
Beyond TB medicines: How quality assurance is elevating health systems in Central Asi...
In the Kyrgyz Republic and Uzbekistan, investments in TB are resulting in broader health benefits, beyond just a single disease.
// June 26, 2023
Complex generics: Are global regulators addressing the needs? ...
The development of generic versions of innovator medicines is a global public health need.
// May 24, 2023
World Vaccine Congress 2023: Spotlight shines on mRNA and viral vectored technology p...
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored technologies was among the key draws at this year’s World Vaccine Congress (WVC) on April 3-6 in Washington, D.C.